You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ERYTHROMYCIN - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for erythromycin and what is the scope of patent protection?

Erythromycin is the generic ingredient in fifty-two branded drugs marketed by Dr Reddys Labs Sa, Parke Davis, Warner Chilcott Llc, Hospira, Azurity, Barr, Norvium Bioscience, Altana, Mylan, Encube, Fougera Pharms, Padagis Us, Syosset, Bausch And Lomb, Pharmaderm, Pharmafair, Sentiss, Dista, Bausch, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, Micro Labs, Epic Pharma Llc, Alpharma Us Pharms, Lilly, Pai Holdings Pharm, Pharmobedient Cnsltg, Renaissance Pharma, Dow Pharm, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Amneal Pharms Co, Torrent, Solvay, Robins Ah, Alembic, Alkem Labs Ltd, Cadila Pharms Ltd, Teva Pharms Usa Inc, Zydus Lifesciences, Zydus Pharms, Watson Labs, Cosette, Life Labs, Amneal Pharms, Ani Pharms, Endo Operations, Ross Labs, Pharmacia And Upjohn, Arbor Pharms Llc, Naska, Wyeth Ayerst, Aurobindo Pharma Usa, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Exela Pharma, Nexus, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin. Thirty-six suppliers are listed for this compound.

Summary for ERYTHROMYCIN

US Patents:	0
Tradenames:	52
Applicants:	70
NDAs:	138
Drug Master File Entries:	103
Finished Product Suppliers / Packagers:	36
Raw Ingredient (Bulk) Api Vendors:	103
Clinical Trials:	136
Patent Applications:	6,076
Drug Prices:	Drug price trends for ERYTHROMYCIN
Drug Sales Revenues:	Drug sales revenues for ERYTHROMYCIN
What excipients (inactive ingredients) are in ERYTHROMYCIN?	ERYTHROMYCIN excipients list
DailyMed Link:	ERYTHROMYCIN at DailyMed

Drug Prices for ERYTHROMYCIN

See drug prices for ERYTHROMYCIN

Drug Sales Revenue Trends for ERYTHROMYCIN

See drug sales revenues for ERYTHROMYCIN

Recent Clinical Trials for ERYTHROMYCIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Takeda	Phase 1
Chang Gung Memorial Hospital	Phase 1/Phase 2
Assiut University	N/A

See all ERYTHROMYCIN clinical trials

Pharmacology for ERYTHROMYCIN

Drug Class	Macrolide Antimicrobial Macrolide
Physiological Effect	Decreased Sebaceous Gland Activity

Medical Subject Heading (MeSH) Categories for ERYTHROMYCIN

Anti-Bacterial Agents
Gastrointestinal Agents
Protein Synthesis Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROMYCIN

US Patents and Regulatory Information for ERYTHROMYCIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	ILOSONE SULFA	erythromycin estolate; sulfisoxazole acetyl	SUSPENSION;ORAL	050599-001	Sep 29, 1989		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Azurity	E.E.S. 400	erythromycin ethylsuccinate	TABLET;ORAL	061905-002	Aug 12, 1982	BX	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lilly	ERYTHROMYCIN	erythromycin	SOLUTION;TOPICAL	050532-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dista	ILOTYCIN	erythromycin	TABLET, DELAYED RELEASE;ORAL	061910-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Barr	E-BASE	erythromycin	TABLET, DELAYED RELEASE;ORAL	062999-001	Nov 25, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cadila Pharms Ltd	ERYTHROMYCIN	erythromycin	TABLET;ORAL	213628-001	Jun 28, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ani Pharms	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	061591-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.